Close Menu

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its third-quarter revenues increased 15 percent and were in line with a pre-announcement the firm made regarding the quarter late last month.

The Sunnyvale, Calif.-based molecular diagnostics firm reported total revenues of $80.5 million for the three months ended Sept. 30, up from $70.2 million for the third quarter of 2011. Wall Street analysts, on average, expected revenues of $81 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.